International Business Machines Corporation (IBM) — Fair Value Analysis

Base-case fair value (P50): $173.74 · Current price: $234.32 · Verdict: Overvalued

The Verdict on IBM

Our Monte Carlo simulations indicate that IBM (IBM) is currently Overvalued. With the stock trading at $234.32, our robust models determine a median fair value (P50) of $173.74. This significant discrepancy suggests a projected -25.9% downside, signaling a considerable disconnect between the market's optimistic current valuation and our intrinsic assessment for this Technology sector veteran. Investors reviewing IBM should pay close attention to this valuation gap, which our analysis identifies as a critical risk factor, especially given the stock's performance relative to its calculated intrinsic worth.

How IBM stacks up against Technology

IBM's market position within the dynamic Technology sector is further complicated by its "weak" quality tier. This rating reflects an assessment of operational and financial health that, unfortunately, trails many of its sector peers. While the broader Technology sector frequently commands premium valuations due to innovation and growth potential, IBM's intrinsic value, as indicated by our $173.74 estimate, struggles to justify its $234.32 in light of its underlying structural quality. The substantial -25.9% negative return potential underscores the hurdles IBM faces in a fiercely competitive landscape where companies with stronger fundamentals might offer more attractive risk-reward profiles to discerning investors.

What this means for investors

The Overvalued verdict for IBM, primarily driven by the substantial gap between its current trading price of $234.32 and our calculated $173.74 fair value, points to significant potential headwinds. Investors considering an allocation to IBM should carefully weigh the -25.9% implied downside against the company's designated "weak" quality tier. Our FairCurve analysis suggests that at $234.32, the market may be pricing in expectations for growth or operational stability that are not fully supported by the underlying fundamentals captured across thousands of our simulations. For a comprehensive understanding of IBM's full valuation spectrum, sign up for FairCurve to see the complete bear and bull case distribution and track its fair value as new fundamentals are released.

Frequently Asked Questions

Is IBM overvalued or undervalued right now?

Based on our Monte Carlo simulations, IBM is currently overvalued. Its current price of $234.32 is significantly higher than our median fair value estimate (P50) of $173.74.

What is the bear case and bull case for IBM?

The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.

How does FairCurve calculate IBM's fair value?

FairCurve calculates IBM's fair value using advanced Monte Carlo simulations, running thousands of forward scenarios to determine a robust intrinsic value estimate.

How can I track IBM's fair value as it changes?

You can add IBM to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings reports or significant fundamental data are released.